The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Novo A/s since year 2005.
The trader's CIK number is 1388325.
At the time of this reporting, Novo A/s is the 10% Owner of Biomimetic Therapeutics, Inc. .
(stock ticker symbol BMTI).
See this page for all insider trading activities at Biomimetic Therapeutics, Inc. .
Stock purchases, sales, and option exercises reported by insider Novo A/s since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-06-24
BMTI
Biomimetic Therapeutics, Inc.
Purchase
248,202
11.00
2,730,222
2008-05-22
BMTI
Biomimetic Therapeutics, Inc.
Purchase
12,931
10.95
141,597
2008-05-13
BMTI
Biomimetic Therapeutics, Inc.
Purchase
7,843
10.96
85,933
2008-05-09
BMTI
Biomimetic Therapeutics, Inc.
Purchase
25,100
10.87
272,940
2008-05-07
BMTI
Biomimetic Therapeutics, Inc.
Purchase
13,769
10.26
141,201
2008-05-08
BMTI
Biomimetic Therapeutics, Inc.
Purchase
12,596
10.45
131,623
2008-05-07
BMTI
Biomimetic Therapeutics, Inc.
Purchase
7,792
10.53
82,035
2008-05-08
BMTI
Biomimetic Therapeutics, Inc.
Purchase
6,843
10.29
70,431
2008-05-08
BMTI
Biomimetic Therapeutics, Inc.
Purchase
11,300
10.36
117,119
2008-05-06
BMTI
Biomimetic Therapeutics, Inc.
Purchase
8,309
10.51
87,347
2008-05-06
BMTI
Biomimetic Therapeutics, Inc.
Purchase
10,600
9.83
104,217
2008-05-06
BMTI
Biomimetic Therapeutics, Inc.
Purchase
15,191
10.26
155,840
2008-05-05
BMTI
Biomimetic Therapeutics, Inc.
Purchase
39,182
10.63
416,397
2008-05-02
BMTI
Biomimetic Therapeutics, Inc.
Purchase
700
10.50
7,350
2008-04-29
BMTI
Biomimetic Therapeutics, Inc.
Purchase
253,693
9.88
2,506,296
2008-04-28
BMTI
Biomimetic Therapeutics, Inc.
Purchase
35,000
9.90
346,634
2008-04-28
BMTI
Biomimetic Therapeutics, Inc.
Purchase
9,200
10.13
93,196
2008-04-25
BMTI
Biomimetic Therapeutics, Inc.
Purchase
11,392
10.08
114,786
2007-01-25
BMTI
Biomimetic Therapeutics, Inc.
Purchase
335,575
12.46
4,180,459
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Novo A/s
(10% Owner of Biomimetic Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
